Jupiter Neurosciences, Inc.
JUNS
$5.24
-$0.76-12.67%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -14.22% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -14.22% | -- | |||
| Cost of Revenue | 767.22% | -94.13% | |||
| Gross Profit | -1,420.31% | 96.80% | |||
| SG&A Expenses | -43.72% | 87.97% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -29.99% | 23.22% | |||
| Operating Income | 30.11% | -22.28% | |||
| Income Before Tax | 19.92% | -12.54% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 19.92% | -12.54% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 19.92% | -12.54% | |||
| EBIT | 30.11% | -22.28% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 13.20% | -0.30% | |||
| Normalized Basic EPS | 21.79% | -11.43% | |||
| EPS Diluted | 13.72% | -0.89% | |||
| Normalized Diluted EPS | 21.79% | -11.43% | |||
| Average Basic Shares Outstanding | -7.66% | 12.16% | |||
| Average Diluted Shares Outstanding | -7.66% | 12.16% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||